|
|
||||||||
American Journal of Roentgenology, Vol 159, 869-874, Copyright © 1992 by American Roentgen Ray Society
ARTICLES |
JJ Caro, E Trindade and M McGregor
Department of Medicine, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.
OBJECTIVE. Our purpose was to assess the cost-effectiveness of substituting low-osmolality contrast media for high-osmolality media in noncardiac parenteral use in radiology. MATERIALS AND METHODS. Estimates of effectiveness, taken as the reduction in risks of reactions affecting safety and comfort, were based on a recent meta- analysis of data published since 1980. Costs were those of the contrast medium and of treating reactions. RESULTS. One hundred thousand uses of low-osmolality media instead of high-osmolality media would cost an additional $7.7 million. No deaths would be prevented, but there would be 80% fewer life-threatening events and 75% fewer minor reactions. Considering only life-threatening events, complete conversion to low- osmolality media costs $62,000 per event prevented. If only minor reactions are considered, this figure is $800 per event prevented. The cost-effectiveness of partial substitution of low-osmolality media in "high-risk" patients only cannot be estimated with confidence. With one set of assumptions, a 33% reduction in life-threatening reactions at a cost of $22,000 per event prevented is estimated. These estimates are insensitive to all inputs except the cost differential between high- and low-osmolality media: for every dollar decrease in cost differential per use, the cost per life-threatening event prevented drops by $790. CONCLUSION. The allocation of limited resources requires the best available information on the relevant costs and benefits. A policy of substitution of low- for high-osmolality media will not influence mortality and will bring fairly small benefits at a considerable cost.
This article has been cited by other articles:
![]() |
M. K. Varma, K. Price, V. Jayakrishnan, B. Manickam, and G. Kessell Anaesthetic considerations for interventional neuroradiology Br. J. Anaesth., July 1, 2007; 99(1): 75 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Li, C S Wong, M K Wong, C M Lee, and M C Au Yeung Acute adverse reactions to magnetic resonance contrast media - gadolinium chelates Br. J. Radiol., May 1, 2006; 79(941): 368 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Megibow, G. Jacob, J. P. Heiken, E. K. Paulson, K. D. Hopper, G. Sica, S. Saini, B. A. Birnbaum, R. Redvanley, and E. K. Fishman Quantitative and Qualitative Evaluation of Volume of Low Osmolality Contrast Medium Needed for Routine Helical Abdominal CT Am. J. Roentgenol., March 1, 2001; 176(3): 583 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Jacobson and C. J. Rosenquist The Use of Low-Osmolar Contrast Agents: Technological Change and Defensive Medicine Journal of Health Politics Policy and Law, June 1, 1996; 21(2): 243 - 266. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |